University of Illinois at Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Illinois at Chicago sits in the top decile of US sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count).
University of Illinois at Chicago: 430 sponsored US clinical trials, 115 recruiting.
University of Illinois at Chicago sponsors 430 registered US clinical trials on ClinicalTrials.gov, 115 of them currently recruiting, and 236 completed. 30 of these trials are in Phase 3-4 (later-stage) and 80 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Multiple Sclerosis, with 10 trials.
Top-decile sponsor footprint
University of Illinois at Chicago ranks in the top decile of sponsors by registered trial count (#83 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
236 of 271 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
430 total, page 4 of 9
BRE-06: Study to Increase Tolerance to Aromatase Inhibitors for Patients With Early-Stage Hormone Receptor Positive Breast Cancer Who Developed Hypoactive Sexual Desire Disorder
NCT07596212
Chicago Data-driven Opioid Use Disorder Screening, Engagement, Treatment and Planning System
NCT07498322
Maternal Outcomes: Mood, Alcohol Use, and Depressive Symptoms
NCT07485036
PACU Discharge Readiness
NCT07588542
Cognitive-Motor Training for AD/ADRD Prevention
NCT07160582
We Need to FEED: Facilitating Enteral Education for Discharge
NCT07383272
Synergistic Minimally Invasive Surgery and Deferoxamine in ICH
NCT07162363
Short-Term Health Outcomes of Cooking UFP Exposure
NCT07311967
Remote Pharmacy Services Plus Continuous Glucose Monitoring in an Underserved Population
NCT07587151
Pilot Sleep Extension and Mood
NCT06675799
Active Balance and Cardio Care Intervention on Physical and Cardiovascular Health in People With Chronic Stroke
NCT06060470
Targeting Chronic Stress for Reducing Risk Factors for Colorectal Cancer
NCT06323421
Facilitating Advance Care Planning Discussions for People With Advanced Cancer
NCT06061965
WeCanManage. An mHealth Self-management Tool
NCT06185738
Upper Limb-based Movement Priming for Lower Limb Neuroplasticity & Motor Recovery in Stroke
NCT05919043
Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke
NCT05906602
Feasibility of Remote Exercise Training for Hispanics/Latinos With MS
NCT05998616
Pilot Trial to Evaluate PROblem Solving Therapy and APPLE Watch for College Students
NCT06333288
Circadian Amplification in Diabetic Retinopathy
NCT06183476
Neurocognitive Mechanisms of Perimenstrual Estrogen Effects on Suicidality
NCT06191289
Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease
NCT05204329
High-intensity Inspiratory Muscle Training as a Pre-cardiac Rehabilitation in Heart Disease
NCT06127147
Intermittent Fasting in Adults With Type 1 Diabetes
NCT06134986
Time Restricted Eating With or Without a Fiber Supplement for Weight Management in Pediatric Cancer Survivors
NCT05826184
Building Resilience for Advance Care Planning (ACP) in Chinese Americans
NCT06247215
Time Restricted Eating Plus Exercise for Weight Management
NCT05290233
Cognitive Enhancement and Risk-reduction Through Exercise for Brain-Related Outcomes
NCT05588778
The SHARED, Project, Lung Cancer Screening for African American Men (AAM)
NCT05920850
Predictors and Consequences of Combustible Cigarette Smokers' Switch to Standardized Research E-Cigarettes
NCT03277495
Promoting Genetic Counseling Among African American Women With a Family History of Breast Cancer
NCT04378751
Preparing a Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
NCT05796648
The Effect of rPMS on Motor Skill Performance in Persons With a Stroke.
NCT05833490
Transnasal Esophagoscopy (TNE) Esophageal Cancer Screening
NCT05480891
Promoting In-Home Activities at a Memory & Aging Clinic
NCT05771064
Reducing Stress-Sensitive Problems Among Pregnant Black Women With Childhood Adversity
NCT05718479
Study of a PST-Trained Voice-Enabled Artificial Intelligence Counselor(SPEAC) for Adults With Emotional Distress (Phase 2)
NCT05603923
Time Restricted Eating for the Treatment of PCOS
NCT05629858
Feasibility of Implementing Acupuncture Into Federally Qualified Health Center Among Breast Cancer Survivors
NCT05615753
Dilution of Verapamil During Intraarterial Administration
NCT05625503
Online Intervention to Promote Resilience to Traumatic Stress During Pregnancy
NCT04992767
Blood Flow and Blood Pressure Investigation in Down Syndrome
NCT05528549
Post-operative Pain Control With Acetaminophen and Ibuprofen After Functional Endoscopic Sinus Surgery
NCT05287217
The Effect of Ischemic Conditioning on Strength and Ambulation in Subjects with PAD
NCT04937179
Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML)
NCT04926285
Feasibility Testing a Meditation App for Youth in the Legal System
NCT05146167
Time Restricted Eating for the Treatment of Type 2 Diabetes
NCT05225337
Caria: Digital Intervention for Menopause Symptom
NCT04882982
Feasibility or Oral Lactoferrin to Prevent Iron Deficiency Anemia in Obese Pregnancy
NCT04810546
Smart Prostate Specific Antigen (PSA) Screening Study
NCT04782713
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
NCT04906447
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 37 |
| Phase 2 | 43 |
| Phase 3 | 11 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the University of Illinois at Chicago pipeline
115 recruiting of 430 indexed (27% open); 236 completed (55%).
Phase mix: 30 late (III/IV) vs 80 early (I/II) (early-phase heavy).
Top condition: Multiple Sclerosis (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Illinois at Chicago: open-pipeline peers nationwide
Peers matched on 430 registered trials and 27% open enrollment, not the therapeutic-area sidebar.
University of Illinois at Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 430 trials (± recruiting share)
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
- Dartmouth-Hitchcock Medical Center · 427 trials · 12% recruiting
Sponsors near 27% open enrollment (± trial volume)
- Coherus Oncology · 27% recruiting · 15 trials
- NewAmsterdam Pharma · 27% recruiting · 15 trials
- Portland VA Medical Center · 27% recruiting · 15 trials
- White River Junction Veterans Affairs Medical Center · 27% recruiting · 15 trials
Related
What to do with this University of Illinois at Chicago page
430 registered trials is a research-attention snapshot, not an endorsement of University of Illinois at Chicago or any single study.
- 115 of University of Illinois at Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Multiple Sclerosis is the condition University of Illinois at Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Multiple Sclerosis trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Illinois at Chicago pipeline card: 430 registered trials from official public datasets.Report a data error.